Clinical Trial Update: Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating peginterferon alfa-2b in adults with chronic hepatitis B and chronic hepatitis D co-infection; results from Study P04603 were completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis D, Chronic, Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-01-17